| pubmed-article:19647928 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0520997 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19647928 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:19647928 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19647928 | pubmed:dateCreated | 2009-10-5 | lld:pubmed |
| pubmed-article:19647928 | pubmed:abstractText | The female sex is associated with increased stroke severity and relatively poor functional recovery. Several studies have demonstrated that women with stroke benefit more from intravenous thrombolysis compared with men, while others found the nullification of gender effect among women treated with recombinant tissue plasminogen activator (rtPA). The purpose of our study was to determine any gender differences in the efficacy and safety of systemic thrombolysis among patients with acute ischemic stroke in Serbia. | lld:pubmed |
| pubmed-article:19647928 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19647928 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647928 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19647928 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19647928 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19647928 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19647928 | pubmed:issn | 1872-6968 | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Zivkovi?MM | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Kosti?V SVS | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Pekmezovi?TT | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Besla?-Bumbas... | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Jovanovi?D... | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:Budimki?MM | lld:pubmed |
| pubmed-article:19647928 | pubmed:author | pubmed-author:SETIS... | lld:pubmed |
| pubmed-article:19647928 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19647928 | pubmed:volume | 111 | lld:pubmed |
| pubmed-article:19647928 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19647928 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19647928 | pubmed:pagination | 729-32 | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:meshHeading | pubmed-meshheading:19647928... | lld:pubmed |
| pubmed-article:19647928 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19647928 | pubmed:articleTitle | Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study. | lld:pubmed |
| pubmed-article:19647928 | pubmed:affiliation | Institute of Neurology, School of Medicine, Clinical Centre of Serbia, 11000 Belgrade, Serbia. djovanovic@mail.neurologija.bg.ac.rs | lld:pubmed |
| pubmed-article:19647928 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19647928 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19647928 | pubmed:publicationType | Multicenter Study | lld:pubmed |
